This new drug based on telomeres/ telomerase concept must be reviewed by all who are interested in finding cure for hematological cancers. In pilot trials at Mayo it got CRa and CIs . Now the trials are run by Janssen (J&J). check FDA trials list. I believe that this drug will be a game changing drug for hematological cancers in just a few years or less and Revlimid will be outperformed.